Osteoarthritis News and Research

Latest Osteoarthritis News and Research

UK researcher receives IOF-Servier Young Investigator Research Grant

The IOF-Servier Young Investigator Research Grant has been awarded to Dr Mark Edwards, clinical research fellow at the MRC Lifecourse Epidemiology Unit at Southhampton General Hospital in the UK.

27 Mar 2012

Study identifies major gene affecting chronic pain sensitivity

Nearly one in five people suffers from the insidious and often devastating problem of chronic pain.

27 Mar 2012

Early growth predicts strength of the hip bone in childhood

Researchers from the MRC Lifecourse Epidemiology Unit, University of Southampton, have presented evidence that early growth predicts the size, mineralisation, shape and strength of the hip bone in childhood.

26 Mar 2012

Synthetic pasta-like objects are major chemistry advances for regenerative medicine

Medicine's recipe for keeping older people active and functioning in their homes and workplaces - and healing younger people injured in catastrophic accidents - may include "noodle gels" and other lab-made invisible filaments that resemble uncooked spaghetti with nanoscale dimensions, a scientist said here today at the 243rd National Meeting & Exposition of the American Chemical Society (ACS).

26 Mar 2012

$Economic burden of fragility fractures in Europe far exceeds previous estimates$

Economic burden of fragility fractures in Europe far exceeds previous estimates

Researchers at the European Congress of Osteoporosis & Osteoarthritis in Bordeaux have presented new data * which shows that the economic burden of fragility fractures in the 27 member states of the European Union far exceeds previous estimates, with hip fractures accounting for around 55% of costs.

26 Mar 2012

Osteoporosis researcher receives IOF Medal of Achievement

Today, at the European Congress on Osteoporosis & Osteoarthritis, Professor Cyrus Cooper was awarded the International Osteoporosis Foundation (IOF) Medal of Achievement.

26 Mar 2012

Antidepressants can play a key role in relieving pain associated with OA

Antidepressants can play a key role in alleviating painful conditions like osteoarthritis and may result in fewer side effects than traditionally prescribed drug regimes, such as anti-inflammatories and opioids, according to a perspective paper published online ahead of print publication by the International Journal of Clinical Practice.

22 Mar 2012

Tomosynthesis may be more beneficial in diagnosing knee OA than X-ray imaging

A recent study done by researchers at Boston University School of Medicine (BUSM) shows that tomosynthesis may be more beneficial in diagnosing knee osteoarthritis than X-ray imaging.

22 Mar 2012

$Large geographic variation in risk of hip fracture$

Large geographic variation in risk of hip fracture

An extensive study of country-specific risk of hip fracture and 10-year probability of a major fragility fracture has revealed a remarkably large geographic variation in fracture risk. Even accounting for possible errors or limitations in the source data, there was an astonishing 10-fold variation in hip fracture risk and fracture probability between countries.

22 Mar 2012

Ampio receives U.S. patent allowance for lead drug Ampion

Ampio Pharmaceuticals, Inc., a biopharmaceutical company conducting clinical trials on its three lead drugs, licensing distribution of these drugs and engaged in further drug development, today announced that it has received notice of allowance from the US Patent Office of an additional patent that complements and expands its anti inflammatory patent portfolio for its lead drug Ampion.

20 Mar 2012

Sanofi enters definitive agreement to acquire Pluromed

Sanofi and Pluromed Inc. announced today that they have entered into a definitive agreement under which Sanofi is to acquire Pluromed Inc., a medical device company based in Woburn, Massachusetts.

17 Mar 2012

Biomedical research advances through new Australian Institute

The Institute of Biomedical Engineering and Technology (BMET) will be officially opened this evening at the University of Sydney, and will significantly advance this highly multidisciplinary research for life sciences and medicine.

14 Mar 2012

FDA panel favors continued research on novel pain medicine

A panel of experts for the U.S. Food and Drugs Administration (FDA) this Monday recommended that the federal government should allow continued testing of an experimental class of pain drugs for arthritis, despite links to bone decay and joint failure.

13 Mar 2012